| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025997 |
| Receipt No. | R000029886 |
| Official scientific title of the study | A study on the effectiveness of SRRA001(development code) |
| Date of disclosure of the study information | 2017/02/06 |
| Last modified on | 2018/01/29 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A study on the effectiveness of SRRA001(development code) | |
| Title of the study (Brief title) | A study on the effectiveness of SRRA001(development code) | |
| Region |
|
|
| Condition | |||
| Condition | Healthy individuals with relatively-deteriorated sleep health | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To confirm the effectiveness of SRRA001(development code) for improvement of sleep quality |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Subjective and objective indicators on sleep quality before and after the intake of test foods for 8 days |
| Key secondary outcomes | Autonomic nervous activity, physical activity and biochemical components in blood and saliva before and after the intake of test foods for 8 days |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | SRRA001(development code) ingestion
(Once a day for 8 days, before sleep onset) (Wash out for 3 weeks) Placebo ingestion (Once a day for 8 days, before sleep onset) |
|
| Interventions/Control_2 | Placebo ingestion
(Once a day for 8 days, before sleep onset) (Wash out for 3 weeks) SRRA001(development code) ingestion (Once a day for 8 days, before sleep onset) |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1.Healthy male, age >=20 and <=59 years
2.Individuals whose PSQI score is higher than average score. |
|||
| Key exclusion criteria | 1.Individuals attending a hospital or using medical products
2.Individuals using medical products for pollinosis 3.Individuals who have chronic illness 4.Individuals who have a history of serious disease (heart disease, kidney damage, diabetes, cancer, and so on) 5.Individuals who are sensitive to medical tapes or electrodes 6.Individuals who participate in the other examinations which have an influence on this examination 7.Individuals judged inappropriate for the study by the principal |
|||
| Target sample size | 32 | |||
| Research contact person | |
| Name of lead principal investigator | Takatoshi Murase |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | 0285-68-7871 |
| murase.takatoshi@kao.co.jp | |
| Public contact | |
| Name of contact person | Yasunori Yamamoto |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | 0285-68-7468 |
| Homepage URL | |
| yamamoto.yasunori@kao.co.jp | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029886 |